ADMA Biologics, Inc. (ADMA)
9.63
-1.70
(-15.00%)
USD |
NASDAQ |
Mar 25, 16:00
9.45
-0.18
(-1.87%)
After-Hours: 07:55
ADMA Biologics Free Cash Flow : 27.50M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AtriCure, Inc. | 48.28M |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Ligand Pharmaceuticals, Inc. | 38.04M |
| ANI Pharmaceuticals, Inc. | 150.90M |
| Terns Pharmaceuticals, Inc. | -77.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 35.64M |
| Cash from Investing (Quarterly) | -0.276M |
| Cash from Financing (Quarterly) | -9.118M |
| Free Cash Flow Per Share (Quarterly) | 0.1409 |
| Free Cash Flow to Equity (Quarterly) | 37.60M |
| Free Cash Flow to Firm (Quarterly) | 35.67M |
| Free Cash Flow Yield | 1.16% |